Human rhinoviruses (HRV), the cause of common colds, are the most frequent precipitants of acute exacerbation of asthma and chronic obstructive pulmonary disease, as well as causes of other serious respiratory diseases. No vaccine or antiviral agents are available for the prevention or treatment of HRV infection. Resveratrol exerts antiviral effect against different DNA and RNA viruses. The antiviral effect of a new resveratrol formulation containing carboxymethylated glucan was analyzed in H1HeLa cell monolayers and ex vivo nasal epithelia infected with HRV-16. Virus yield was evaluated by plaque assay and expression of viral capsid proteins by Western blot. IL-10, IFN-β, IL-6, IL-8 and RANTES levels were evaluated by ELISA assay. ICAM-1 was assessed by Western blot and immunofluorescence. Resveratrol exerted a high, dose-dependent, antiviral activity against HRV-16 replication and reduced virus-induced secretion of IL-6, IL-8 and RANTES to levels similar to that of uninfected nasal epithelia. Basal levels of IL-6 and RANTES were also significantly reduced in uninfected epithelia confirming an anti-inflammatory effect of the compound. HRV-induced expression of ICAM-1 was reversed by resveratrol. Resveratrol may be useful for a therapeutic approach to reduce HRV replication and virus-induced cytokine/chemokine production.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.antiviral.2015.08.010 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Pharmacological rescue of the G85E CFTR variant by preclinical and approved modulators.
Front Pharmacol
November 2024
UOC Genetica Medica, IRCCS Istituto Giannina Gaslini, Genova, Italy.
Article Synopsis
- * Researchers investigated the G85E-CFTR variant using human nasal epithelial cells and found that the drugs elexacaftor and tezacaftor modestly improved CFTR function, but chronic treatment with ivacaftor had negative effects.
- * The study suggests that combining elexacaftor with a new corrector, ARN23765, can significantly enhance CFTR activity and highlights the need for better drug combinations to help patients with the G85E mutation.
Supporting respiratory epithelia and lowering inflammation to effectively treat common cold symptoms: A randomized controlled trial.
PLoS One
November 2024
Applied Biological Laboratories Inc, New York, NY, United States of America.
Common cold viruses are leading triggers of asthma attacks, causing nearly two million hospitalizations per year and productivity losses approaching $40B. They also increase susceptibility to bacterial infections driving antibiotic use. Post-market clinical studies have questioned the efficacy of most over the counter (OTC) cough and cold ingredients against placebo in treating various symptoms.
View Article and Find Full Text PDFIncreased Susceptibility of Bats to Respiratory SARS-CoV-2 Challenge Despite Its Distinct Tropism for Gut Epithelia in Bats.
Viruses
October 2024
Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Suedufer 10, 17493 Greifswald-Insel Riems, Germany.
Article Synopsis
- Bats are considered the primary hosts for many coronaviruses, particularly Betacoronaviruses, which can cause severe respiratory diseases in humans.
- Research showed that Egyptian fruit bats were more susceptible to respiratory infections (like SARS-CoV-2) compared to oral infections, with significant differences in virus shedding and immune response.
- The study suggests that SARS-CoV-2 is likely inactivated in the bats' stomachs, making oral infections less effective, highlighting the unique pathology of coronavirus infections in bats.
The Functional Impact of VX-770 on the Cystic Fibrosis Transmembrane Conductance Regulator Is Enduring and Increases the Constitutive Activity of This Channel in Primary Airway Epithelia Generated from Healthy Donors.
Biomolecules
October 2024
Department of Pediatrics, National Jewish Health, Denver, CO 80206, USA.
VX-770 is a small-molecule CFTR potentiator that is highly efficacious in individuals with cystic fibrosis caused by mutations in CFTR that result in a defect in channel gating. While studies have reported on the mechanism of action of VX-770, there is still more to learn about the impact that it has on CFTR function in various contexts. The aim of the present study was to examine the longevity and stability of the effect of VX-770 on CFTR function in cultured airway epithelia and to measure the consequences of this interaction.
View Article and Find Full Text PDFOlfactory and trigeminal routes of HSV-1 CNS infection with regional microglial heterogeneity.
J Virol
November 2024
Department of Cell and Developmental Biology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Article Synopsis
- HSV-1 primarily infects the oral and nasal areas before establishing latency in the trigeminal ganglion and can also infect the central nervous system (CNS) via specific pathways.
- Recent studies have highlighted the lack of detailed knowledge about which brain regions are affected during HSV-1 infections and how microglial responses differ across these regions.
- This study on a mouse model revealed a two-step spread of HSV-1 from the olfactory epithelium to select brain regions, along with varying activation levels of microglia, contributing to understanding HSV-1's role in neurological diseases.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!